Science Advisory Board

Dr. Robert Langer, Institute Professor, Massachussetts Institute of Technology

Robert S. Langer is one of 14 Institute Professors (the highest honor awarded to a faculty member) at the Massachusetts Institute of Technology (MIT). Dr. Langer has written over 1,000 articles. He also has more than 600 issued or pending patents worldwide. Dr. Langer’s patents have been licensed or sublicensed to over 200 pharmaceutical, chemical, biotechnology and medical device companies. He is the most cited engineer in history.

Dr. Langer has received over 160 major awards including the 2006 United States National Medal of Science; the Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers and the 2008 Millennium Prize, the world’s largest technology prize. He is the also the only engineer to receive the Gairdner Foundation International Award; 72 recipients of this award have subsequently received a Nobel Prize.
Among numerous other awards Langer has received are the Dickson Prize for Science (2002), Heinz Award for Technology, Economy and Employment (2003), the Harvey Prize (2003), the John Fritz Award (2003) (given previously to inventors such as Thomas Edison and Orville Wright), the General Motors Kettering Prize for Cancer Research (2004), the Dan David Prize in Materials Science (2005), the Albany Medical Center Prize in Medicine and Biomedical Research (2005), the largest prize in the U.S. for medical research, induction into the National Inventors Hall of Fame (2006), the Max Planck Research Award (2008) and the Prince of Asturias Award for Technical and Scientific Research (2008). In 1998, he received the Lemelson-MIT prize, the world’s largest prize for invention for being “one of history’s most prolific inventors in medicine.” In 1989 Dr. Langer was elected to the Institute of Medicine of the National Academy of Sciences, and in 1992 he was elected to both the National Academy of Engineering and to the National Academy of Sciences. He is one of very few people ever elected to all three United States National Academies and the youngest in history (at age 43) to ever receive this distinction.

Forbes Magazine (1999) and Bio World (1990) have named Dr. Langer as one of the 25 most important individuals in biotechnology in the world. Discover Magazine (2002) named him as one of the 20 most important people in this area. Forbes Magazine (2002) selected Dr. Langer as one of the 15 innovators world wide who will reinvent our future. Time Magazine and CNN (2001) named Dr. Langer as one of the 100 most important people in America and one of the 18 top
people in science or medicine in America (America’s Best). Parade Magazine (2004) selected Dr. Langer as one of 6 “Heroes whose research may save your life.” Dr. Langer has received honorary doctorates from Yale University, the ETH (Switzerland), the Technion (Israel), the Hebrew University of Jerusalem (Israel), the Universite Catholique de Louvain (Belgium), the University of Liverpool (England), the University of Nottingham (England), Albany Medical College, the Pennsylvania State University, Northwestern University and Uppsala University (Sweden). He received his Bachelor’s Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering.
Dr. Donald T. Haynie, Co-Founder and Senior Technical Advisor
Dr. Haynie advises ACT on the biophysics of Artificial Cells and polypeptide layer-by-layer self-assembly. He co-founded Artificial Cell Technologies to commercialize his work on designed polypeptide multilayer nanofilms. He earned the doctorate in biophysics from The Johns Hopkins University and was awarded a National Science Foundation post-doctoral fellowship for investigation of biological macromolecules at University of Oxford. He has been a lecturer in biochemistry, Assistant Research Professor of Physics, Associate Professor of Biomedical Engineering and Physics, Director of the Bionanosystems Engineering Laboratory, Research Professor of Biochemistry and Biophysics, and a clinical professor of surgery. He has been Principal Investigator of research sponsored by Medical Research Council (UK), Royal Society (UK), National Science Foundation (USA), National Institutes of Health (USA), and other organizations. He is a Fellow and a Member of the Board of Directors of the American Academy of Nanomedicine, Associate Editor of Nanomedicine: Nanotechnology, Biology, and Medicine, and a member of the editorial advisory board of Recent Patents in Biotechnology and Recent Patents in Nanotechnology. He has multiple issued and pending patents. His book, Biological Thermodynamics (Cambridge University Press, 2nd edition 2008) is widely considered the definitive introduction to the subject.
ACT's Science Advisory Board (SAB) includes some of the nation’s most preeminent minds in areas of vaccines, biomaterials, and bionanotechnology.  The SAB advises the company's scientific and management teams on scientific strategy and includes the following key members: